March SAS-B approvals hit third highest on record by Steve Jones April 1, 2026April 1, 2026 Approvals through the Special Access Scheme exceeded 20,000 for only the third time last month, with […]
SAS-B deep dive: approvals climb 26% in 2025 as flower overtakes oil and pastilles surge by Adam Sheldon January 13, 2026January 14, 2026
SAS-B approvals slow in August but pastille scripts continue to rise by Steve Jones September 3, 2025February 21, 2026
July SAS-B approvals edge higher as pastilles share rises beyond 20% by Adam Sheldon August 5, 2025August 6, 2025
SAS-B deep dive: approvals up 27% as flower officially overtakes oil by Adam Sheldon July 3, 2025July 3, 2025
SAS-B deep dive: approvals soar in ’24 with category five medicine leading the charge by Steve Jones January 22, 2025January 22, 2025
Pastilles continue steady SAS-B growth but flower retains top spot by Steve Jones December 4, 2024April 11, 2025
